Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity.

Adiposity Body Composition Humans Nutrition Surveys Obesity / complications Sarcopenia / diagnosis
Obesity Physical function Sarcopenia

Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
12 2020
Historique:
received: 04 03 2020
revised: 22 06 2020
accepted: 22 07 2020
pubmed: 16 9 2020
medline: 29 10 2021
entrez: 15 9 2020
Statut: ppublish

Résumé

This study aims to assess the construct validity of a body composition-defined definition of sarcopenic obesity based on low appendicular lean mass relative to fat mass (ALMI This is a secondary analysis of two cohort studies: the National Health and Examination Survey (NHANES) and the Health, Aging, and Body Composition study (Health ABC). Sarcopenic obesity was defined as low ALMI Among 14, 850 participants from NHANES, patients with sarcopenic obesity defined by low ALMI Body composition-defined measures of sarcopenic obesity defined as excess adiposity and lower-than-expected ALMI relative to FMI are associated with functional deficits and incident disability and overcome the limitations of using %BF in estimating obesity in this context.

Sections du résumé

BACKGROUND
This study aims to assess the construct validity of a body composition-defined definition of sarcopenic obesity based on low appendicular lean mass relative to fat mass (ALMI
METHODS
This is a secondary analysis of two cohort studies: the National Health and Examination Survey (NHANES) and the Health, Aging, and Body Composition study (Health ABC). Sarcopenic obesity was defined as low ALMI
RESULTS
Among 14, 850 participants from NHANES, patients with sarcopenic obesity defined by low ALMI
CONCLUSIONS
Body composition-defined measures of sarcopenic obesity defined as excess adiposity and lower-than-expected ALMI relative to FMI are associated with functional deficits and incident disability and overcome the limitations of using %BF in estimating obesity in this context.

Identifiants

DOI: 10.1002/jcsm.12613 PMID: 32931633 PMC: PMC7749601
pubmed: 32931633
doi: 10.1002/jcsm.12613
pmc: PMC7749601
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1580-1589

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK114477
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062101
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062103
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062106
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG028050
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR012459
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK076808
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK111083
Pays : United States

Informations de copyright

© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2079-88
pubmed: 25392147
J Am Geriatr Soc. 2003 Nov;51(11):1602-9
pubmed: 14687390
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145
pubmed: 31661195
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1580-1589
pubmed: 32931633
Obesity (Silver Spring). 2012 Oct;20(10):2101-6
pubmed: 22310233
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
J Nutr Metab. 2017;2017:7307618
pubmed: 28421144
J Rheumatol. 2011 Sep;38(9):2074; author reply 2075
pubmed: 21885521
Stat Med. 2011 Feb 10;30(3):260-76
pubmed: 21213343
PLoS One. 2009 Sep 15;4(9):e7038
pubmed: 19753111
Int J Obes (Lond). 2005 Dec;29(12):1457-63
pubmed: 16077713
J Am Geriatr Soc. 2004 Apr;52(4):502-9
pubmed: 15066063
Clin Nutr. 2020 Aug;39(8):2368-2388
pubmed: 31813698
Am J Clin Nutr. 2017 Jul;106(1):14-15
pubmed: 28615264
J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1439-46
pubmed: 22546961
Aging Clin Exp Res. 2019 Dec 16;:
pubmed: 31845200
J Am Geriatr Soc. 2013 Jun;61(6):974-80
pubmed: 23647372
Eur J Clin Nutr. 1990 Jan;44(1):45-60
pubmed: 2354692
Nat Rev Endocrinol. 2018 Sep;14(9):513-537
pubmed: 30065268
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):654-61
pubmed: 25477427
PLoS One. 2016 Oct 10;11(10):e0164385
pubmed: 27723820
J Nutr Health Aging. 2009 Jun;13(6):538-44
pubmed: 19536422
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):946-952
pubmed: 28958026
J Am Geriatr Soc. 2009 Feb;57(2):251-9
pubmed: 19207142
J Rheumatol. 2003 Jul;30(7):1456-63
pubmed: 12858441
J Am Geriatr Soc. 2007 May;55(5):769-74
pubmed: 17493199
J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):M644-9
pubmed: 11584038
Natl Health Stat Report. 2013 Feb 11;(63):1-3
pubmed: 24992748
Rheumatology (Oxford). 2008 Aug;47(8):1124-31
pubmed: 18448480
Obes Res. 2004 Dec;12(12):1995-2004
pubmed: 15687401
Rheumatology (Oxford). 2017 Jun 1;56(6):981-988
pubmed: 28340012
Am J Clin Nutr. 2005 May;81(5):1018-25
pubmed: 15883424
J Nutr Health Aging. 2015 Nov;19(9):913-21
pubmed: 26482693
Int J Cardiol. 2002 Sep;85(1):89-99
pubmed: 12163213

Auteurs

Joshua F Baker (JF)

Division of Rheumatology, Philadelphia Veterans' Affairs Medical Center, Philadelphia, PA, USA.
Division of Rheumatology, School of Medicine, University of Pennsylvania, 8 Penn Tower Building,, Philadelphia, PA, USA.
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
ORCID: 0000-0003-0799-7563

Tamara Harris (T)

Laboratory of Epidemiology and Population Sciences, Intramural Research Program, NIA, NIH, Bethesda, MD, USA.

Allegra Rapoport (A)

John's Hopkins School of Public Health, Baltimore, MA, USA.

Susan L Ziolkowski (SL)

Department of Medicine and Pediatrics, Stanford University, Palo Alto, CA, USA.

Mary B Leonard (MB)

Department of Medicine and Pediatrics, Stanford University, Palo Alto, CA, USA.

Jin Long (J)

Department of Medicine and Pediatrics, Stanford University, Palo Alto, CA, USA.

Babette Zemel (B)

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

David R Weber (DR)

Division of Endocrinology and Diabetes, Golisano Children's Hospital, University of Rochester, Rochester, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Composition corporelle › Répartition du tissu adipeux › Adiposité › Validation of a description of sarcopenic...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Composition corporelle › Validation of a description of sarcopenic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Validation of a description of sarcopenic...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes nutritionnelles › Validation of a description of sarcopenic...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Validation of a description of sarcopenic...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Manifestations neuromusculaires › Amyotrophie › Sarcopénie › Validation of a description of sarcopenic...